163 Stereotactic Radiofrequency Ablation of Thalamic Nuclei for Drug-Resistant Epilepsy: Single and Multitarget Approaches

View at publisher Summarise with VIRAT
Authors: Riju Dahal, Pritam Gurung, Resha Shrestha, Raju Raj Dhungel, Januka Dhamala, Basant Pant
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: In resource-limited settings, device-based neuromodulation options like DBS are not always accessible or feasible. This study evaluates radiofrequency ablation (RFA) of thalamic nuclei as a pragmatic, lesion-based alternative for patients with drug-resistant epilepsy (DRE) ineligible for resective surgery. METHODS: This retrospective study included eight patients with DRE who underwent stereotactic RFA targeting either the anterior nucleus of the thalamus (ANT) alone or in combination with the centromedian nucleus (CMN) and/or pulvinar. Target selection was based on seizure semiology, video-EEG or stereo-EEG findings, and MRI. ANT was targeted for frontotemporal seizures, CMN for generalized seizures, and pulvinar for posterior onset. RFA was performed using a monopolar electrode with a 0.75 mm probe diameter and 2 mm exposure tip at 75°C for 60 seconds. Seizure and neuropsychological outcomes were assessed during follow-up. RESULTS: Six patients underwent ANT ablation (bilateral: 4; unilateral: 2), and two underwent multitarget ablations (ANT+CMN, CMN+pulvinar). All patients showed a significant reduction in habitual seizures beginning from the first postoperative month. Five patients achieved seizure freedom at > 6 months follow-up (n=6); one had >50% reduction. Two patients with > 3 months follow-up also showed >50% seizure reduction. No cognitive deficits or surgical complications were noted. One patient developed cognitive deficits attributable to tumor recurrence, not the procedure. CONCLUSIONS: Both single and multitarget RFA of the thalamic nuclei were safe and associated with early seizure reduction. ANT ablation was effective in focal frontotemporal DRE, while multitarget approaches benefitted those with generalized or posterior-onset seizures. These results support RFA as a viable, cost-effective alternative to DBS in settings where device-based neuromodulation is not feasible, with implications for global epilepsy care.

Fields of Study & Subjects

Epilepsy research and treatment Deep Brain Stimulation and Movement Disorders Obsessive-Compulsive Spectrum Disorders

Publication details

Journal / source
Neurosurgery
Volume
72
Issue
Supplement_1
Pages
30–30
Publication date
26 March 2026
Language
EN